MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression
about
miRNA expression in colon polyps provides evidence for a multihit model of colon cancerAn in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinomaEstrogen receptor {beta}1 expression is regulated by miR-92 in breast cancerTumorigenicity of the miR-17-92 cluster distilledMicroRNAs: Novel immunotherapeutic targets in colorectal carcinomaMicroRNAs as non-invasive screening biomarkers of colorectal cancerAppraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-AnalysisMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerPost-transcriptional regulation of MTA family by microRNAs in the context of cancerThe miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and diseaseAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Regulating miRNA by natural agents as a new strategy for cancer treatmentThe Role of Bioactive Dietary Components in Modulating miRNA Expression in Colorectal CancerDetection of miRNA as non-invasive biomarkers of colorectal cancerThe myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factorsHeterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a.Vitamin D, intermediary metabolism and prostate cancer tumor progression.miR-18a downregulates DICER1 and promotes proliferation and metastasis of nasopharyngeal carcinomaGenome and transcriptome profiles of CD133-positive colorectal cancer cells.Implication of microRNAs in drug resistance for designing novel cancer therapyTargeting microRNAs in cancer: rationale, strategies and challenges.MiRNA genes constitute new targets for microsatellite instability in colorectal cancerSpecific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma.Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinomaTumor suppressor p53 meets microRNAs.MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancerThe miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.miRNAs as biomarkers for management of patients with colorectal cancer.Reversible, interrelated mRNA and miRNA expression patterns in the transcriptome of Rasless fibroblasts: functional and mechanistic implicationsSerum miRNA profiling identifies miR-150/30a as potential biomarker for workers with damaged nerve fibers from carbon disulfidemiR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells.Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expressionPathway Regulation of p63, a Director of Epithelial Cell FateImplications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.Developmental regulation of microRNA expression in Schwann cells
P2860
Q21135357-E9812216-7763-4D16-9CCD-05FC0F60CF78Q21202158-6CCB1010-ADD4-4EBF-89DC-C19DE1C8CD20Q24595552-16457858-3F35-45ED-BE6A-8D032C3865F7Q24650776-0AB48962-5E3C-4C68-B721-D2F31E0706E5Q26747339-13508D0B-BCEF-46E0-A169-8CF20ED324F6Q26770798-11B6D897-5F00-4648-B47A-BE2C4FA766B3Q26772056-709C52C8-7617-4FCD-B7EF-8BE41BC21FBEQ26775610-DDD1B365-D153-4AC8-804F-46F2977ABB65Q26827361-15FA5AE7-4284-4FE9-A8B9-B69A92391E37Q27015587-8A1966F0-4934-45AF-B4CE-388D57F84C2BQ27024427-3A183EB2-D825-42EF-A0E3-ABE45D4043FDQ27026972-293DED9F-DFC1-4851-8925-8497EF87CD33Q28070764-935849C5-D801-4500-8F64-E6EBA3AD32F5Q28082196-8F55373E-D1D0-45CF-8973-768E55172254Q28295428-7E1F38D7-7AD8-43BB-B446-5B886EEAA88CQ33582905-0A010C72-99A2-4302-8FC8-779B54A49D0BQ33647013-C8102952-3CAD-490B-840F-9838B2F9E76DQ33756203-7D0767CE-58BE-4842-86A6-FC26C7FA17EDQ33855041-1603587E-236F-435D-913B-D7F86FC54877Q33903223-38CD0835-B860-4A75-90C5-7CB5218C33D9Q34141089-35D0833A-630B-4531-9047-02E7D3ABD04AQ34163747-F3D585BE-9B4D-4354-B4D2-42794D993914Q34278697-A21C6917-629D-4A6B-AFA8-082F04998B24Q34283589-BC40FE80-48BD-451E-8298-6632CC9255A0Q34439377-FAEDC8D2-87B1-4C5B-8204-89C33F0329AEQ34499638-7767E7D3-977A-4C47-8F4C-1BB38DD34F04Q34539766-FC05622D-4A2F-46BA-A0C8-89AA0AE07980Q34599928-1905FF01-EF80-4436-86F6-E60E9DB433A4Q34657471-4C2221BC-BE47-4537-90CC-764A0F4BE3F4Q34695995-B0952C4C-C7D1-4D47-85F9-048CF3F849A9Q34729935-56CFB078-EE7E-489C-B045-642663F53DFDQ34808577-0AFA7618-AF16-45CA-8E31-586431783DB9Q35025776-4BE1B86F-11A7-482A-8F72-3C011428C707Q35091209-F8770C44-3311-4C89-BA23-6DEF44846611Q35402694-90BF3B95-E30B-4080-9771-A740ACF03E97Q35476235-C7D27FE8-9EC8-443A-9801-A44011332E66Q35545782-5E2F69F8-F3D8-473D-AA65-D5FD0E7914D1Q35565247-A3AAF8EF-27CA-40B0-9C5E-B784256CD95DQ35622047-6B5049D6-505F-44F0-9760-01F7DF71F9FDQ35665674-40C33EA5-5A68-44D7-8CC5-339065FB04D2
P2860
MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@ast
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@en
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@nl
type
label
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@ast
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@en
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@nl
prefLabel
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@ast
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@en
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@nl
P2093
P2860
P3181
P356
P1476
MiR-17-92 cluster is associate ...... to adenocarcinoma progression
@en
P2093
B Carvalho
B Diosdado
G A Meijer
J S Terhaar Sive Droste
M A van de Wiel
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6605037
P407
P577
2009-08-01T00:00:00Z
P5875
P6179
1009669278